Johnson & Johnson Change in Accounts Receivable 2010-2025 | JNJ
Johnson & Johnson annual/quarterly change in accounts receivable history and growth rate from 2010 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- Johnson & Johnson change in accounts receivable for the quarter ending June 30, 2025 was $-2.280B, a 96.04% increase year-over-year.
- Johnson & Johnson change in accounts receivable for the twelve months ending June 30, 2025 was $-4.875B, a 67.12% increase year-over-year.
- Johnson & Johnson annual change in accounts receivable for 2024 was $-0.395B, a 36.7% decline from 2023.
- Johnson & Johnson annual change in accounts receivable for 2023 was $-0.624B, a 52.26% decline from 2022.
- Johnson & Johnson annual change in accounts receivable for 2022 was $-1.307B, a 46.65% decline from 2021.
Johnson & Johnson Annual Change in Accounts Receivable
(Millions of US $) |
| 2024 |
$-395 |
| 2023 |
$-624 |
| 2022 |
$-1,307 |
| 2021 |
$-2,450 |
| 2020 |
$837 |
| 2019 |
$-309 |
| 2018 |
$-1,216 |
| 2017 |
$-616 |
| 2016 |
$-1,076 |
| 2015 |
$-415 |
| 2014 |
$-275 |
| 2013 |
$-763 |
| 2012 |
$83 |
| 2011 |
$-883 |
| 2010 |
$-195 |
| 2009 |
$511 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$425.770B |
$88.821B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
